NURIX THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
NURIX THERAPEUTICS, INC. (NRIX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $796.00 thousand as of 2021-08-31, per its 10-Q filed 2021-10-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2021-10-14
- 2021-08-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $796.00K.
- 2021-05-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.59M.
- 2021-02-28: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.34M.
- 2020-08-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $830.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2021-08-31 | $796.00K 10-Q · filed 2021-10-14 |
| 2021-05-31 | $1.59M 10-Q · filed 2021-07-13 |
| 2021-02-28 | $2.34M 10-Q · filed 2021-04-13 |
| 2020-08-31 | $830.00K 10-Q · filed 2020-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |